News

Saratoga Investment Corp. Announces $0.75 Dividend for 2026

Saratoga Investment Corp. Announces $0.75 Dividend for 2026

Saratoga Investment Corp. Declares a Monthly Dividend

In a recent announcement, Saratoga Investment Corp. (NYSE: SAR) revealed that it will pay dividends totaling $0.75 per share for the third quarter of fiscal 2026. This will be distributed as monthly dividends of $0.25 each, demonstrating the company's ongoing commitment to delivering consistent returns to its shareholders.

Details on the Dividend Payments

The three monthly dividends for the quarter ending November 30, 2025, are as follows:

Monthly Dividend Breakdown

1. **September 2025**: $0.25, Record date: October 7, 2025, Payment date: October 23, 2025.

2. **October 2025**: $0.25, Record date: November 4, 2025, Payment date: November 20, 2025.

3. **November 2025**: $0.25, Record date: December 2, 2025, Payment date: December 18, 2025.

CEO's Statement on Dividend Strategy

Christian L. Oberbeck, Chairman and CEO, expressed the board's satisfaction with approving the dividend, highlighting that the annualized dividend yield is approximately 12.2%, based on Saratoga's stock price of $24.54. This reflects the company's commitment to providing attractive returns to its shareholders through reliable dividends.

Historical Dividend Performance

Saratoga Investment Corp. has been consistent in its dividend payouts. Here’s a historical overview:

Recent Dividend Trends

The table below outlines dividends for fiscal year 2026 so far:

**Fiscal Q3 2026 (September, October, November 2025)**: All months at $0.25 per share, totaling $0.75.

This marks the commitment to sustaining regular dividend payments, reinforcing shareholder confidence.

Dividend Reinvestment Options for Shareholders

Shareholders have the choice to receive dividends in cash or reinvest them in purchasing more common stock through the company's Dividend Reinvestment Plan (DRIP). This flexibility allows shareholders to enhance their investment seamlessly, based on their financial strategy.

Understanding Saratoga Investment Corp.

Saratoga Investment Corp. is a specialty finance company dedicated to providing tailored financing solutions for U.S. middle-market businesses. The company primarily invests in senior loans and mezzanine debt, ensuring effective partnerships with business owners and financial sponsors to achieve beneficial outcomes.

Saratoga's aim is to create compelling risk-adjusted returns through a combination of current income generation and long-term capital appreciation derived from its diverse investments. The company operates under the regulatory framework of the Investment Company Act of 1940 and is managed externally by Saratoga Investment Advisors, LLC, which specializes in credit-driven strategies.

Financial Strength and Operations

The company has two active SBIC-licensed subsidiaries and manages approximately $500 million in collateralized loan obligations (CLOs). Moreover, they hold significant interests in various financial instruments, ensuring a robust capital base that supports a wide range of financing options.

Frequently Asked Questions

What is the total dividend amount declared by Saratoga Investment Corp. for Q3 2026?

The total dividend declared for the third quarter is $0.75 per share.

When can shareholders expect monthly dividends?

Dividends of $0.25 each will be paid monthly, with payments scheduled for October 23, November 20, and December 18, 2025.

What is the yield based on the current stock price?

The annualized dividend yield is approximately 12.2% based on a stock price of $24.54.

Can shareholders choose how to receive dividends?

Yes, shareholders can opt to receive dividends in cash or reinvest them to buy more shares through the Dividend Reinvestment Plan.

What type of investments does Saratoga focus on?

Saratoga primarily invests in senior and unitranche leveraged loans and mezzanine debt, along with equity investments to finance change of ownership transactions and growth initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Oak Farms Invests in Texas Schools and Students

Updated Category News Views 5

Putting Money Where Their Roots Are You have to hand it to Oak Farms; when they say they're rooted in Texas, they actually back it up with some cold, hard cash. They've lined up $27,500 for schools and students across the state. That's the kind of talking I like to see—straight from the brand to the community ledger. No fluff, just good old-fashioned giving in the form...

Continue Reading
National Solar Tour 2026: Discover Solar Power Live

Updated Category News Views 2

Experience Real-Life Solar Innovations It's always worth raising an eyebrow when a grassroots event, that's been kicking around for over three decades, rolls around just waving at us to take part. The National Solar Tour 2026 is crash-landing this weekend, October 2-4, like clockwork, bringing solar tech right to your front porch, figuratively and literally speaking. Get...

Continue Reading
Teamsters Triumph: Court Backs Workers' Health Benefits

Updated Category News Views 4

Court Orders Health Coverage Amid Creamery Dispute Good grief! Just when you think you've seen all the punches the corporate world can throw, something like this comes along. The court's declaration that Dairy Farmers of America (DFA) must keep providing health care to members of Teamsters Local 597 is pushing back the tides for workers at the St. Albans Creamery. This...

Continue Reading
Sarwant Singh Propels Frost & Sullivan's AI Ambitions

Updated Category News Views 4

A Veteran Strategist Returns to the Fold Sharp moves in the corporate world don't always grab headlines, but sometimes you’ve got to stop and consider the buzzworthy comebacks. Keep your eyes peeled for Sarwant Singh's return to Frost & Sullivan, a noteworthy shift that’s shaping the landscape of digital strategies and beyond. Turning Up the Heat on Digital Innovation...

Continue Reading
Survey Says 92% Report Better Life Post-Rehab

Updated Category News Views 4

92% Say Life Improves After TranquilHearts' Treatment It's not every day you see 92% of folks claiming something actually worked for them, huh? That's exactly the kind of figure TranquilHearts Rehab's alumni claimed in their recent survey about improved quality of life post-treatment. But let's not get ahead of ourselves with high-fives and celebration just yet. Here's...

Continue Reading
El Mansouri Becomes Morocco's First Female PM

Updated Category News Views 5

Breaking Barriers: El Mansouri's Historic Appointment Fatima Ezzahra El Mansouri is now steering the ship as Morocco's first female Prime Minister, a milestone that's taken far too long to reach. After the dust settled from the September 23 legislative elections, El Mansouri emerged from the Authenticity and Modernity Party (PAM) with 97 seats in tow. It's a pivotal...

Continue Reading
Bryan Park's Vision Drives Footprints' Surging Growth

Updated Category News Views 5

An Airman’s Mission of Building Legacies When you think of flooring, 'admired CEOs' probably don’t top the list. Yet here’s Bryan Park, an ex-Air Force veteran, shaking things up and earning a nod from the Denver Business Journal. Named one of the Most Admired CEOs of 2026, Park has taken what began as a small flooring operation and turned it into a national...

Continue Reading
Skiptown Expands into Austin: A New Pet Care Frontier

Updated Category News Views 4

Skiptown Marches into the Heart of Texas A move into Texas? Now that's got potential written all over it. Skiptown's making waves by dropping anchor in Austin with a five-unit franchise agreement. We're talking modern dog daycare and more, right in the heart of Central Texas. First up, fall 2027 is when you can circle the calendar. Expect to see more locations sprout up...

Continue Reading
Kohler's Golf Innovation: No Tees Tour Comes Alive

Updated Category News Views 4

Golf Reinvented: Kohler Hosts No Tees Tour Talk about flipping the script, eh? Kohler's teaming up with the No Tees Tour to host an innovative golfing showdown at The Baths of Blackwolf Run, starting October 1. This isn't your grandpa's golf tour. We're talking fast-paced, head-to-head chipping duels that ditch the long drives for surgical precision. The idea's inspired...

Continue Reading
Ontario Fuels Life Sciences Growth with $1.7M Boost

Updated Category News Views 5

A Jolt for Ontario's Life Sciences Sector Ah, there's fresh energy in the air up north, folks. Ontario's dishing out a solid $1.7 million to give Piramal Pharma Solutions' Aurora facility a serious facelift. This isn't just about shiny new labs. It's about staking a claim, saying, "We're serious players on the global stage." They're not just upgrading infrastructure...

Continue Reading

Top 5 Most Recently Viewed Articles

Monte Rosa's New Licensing Deal with Novartis: A Game Changer

Updated Category News Views 234

Monte Rosa Therapeutics Expands Capabilities with Novartis Collaboration BOSTON — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a pioneering biotechnology company on the front lines of developing molecular glue degrader (MGD) therapies, has made significant strides in its mission. Recently, Monte Rosa finalized a global license agreement with Novartis, aimed at...

Continue Reading
Rosen Law Firm Investigates Claims Against Immutable's IMX Tokens

Updated Category News Views 134

Rosen Law Firm Launches Investigation into Immutable's IMX Tokens Rosen Law Firm, recognized for its commitment to investor rights, is currently investigating potential securities claims against Immutable. This investigation arises from serious allegations that Immutable may have provided materially misleading information about its business practices, particularly...

Continue Reading
Circulate Health Secures $12 Million for Longevity Innovations

Updated Category News Views 248

Circulate Health Secures $12 Million for Longevity Innovations In a significant step forward in the field of longevity, Circulate Health has successfully raised $12 million in seed funding. This financing is primarily led by Khosla Ventures and marks a pivotal moment for the company as it continues its mission to harness the potential of therapeutic plasma exchange (TPE)...

Continue Reading
Investors Urged for Wolfspeed, Inc. Class Action Guidance

Updated Category News Views 231

Understanding the Importance of Seeking Legal Counsel for Wolfspeed, Inc. Investors If you've invested in Wolfspeed, Inc., it's crucial to be aware of your rights and the actions you can take, especially if you've incurred losses over $100,000. The law firm Rosen Law Firm is encouraging investors to act swiftly as there is an important deadline approaching. This article...

Continue Reading
Outset Medical Secures $169 Million Financing for Dialysis Innovation

Updated Category News Views 285

Outset Medical Secures Financing to Enhance Dialysis Solutions Outset Medical, Inc. (NASDAQ: OM), a pioneering medical technology company, has successfully entered into a significant financing agreement that stands to transform dialysis care. With a private placement expected to generate approximately $169 million, the company is poised to leverage these funds to expand...

Continue Reading